Will Insurance or a Government Scheme — Pay for Cetuximab?

You can check PM-JAY eligibility through the official PM-JAY portal using your mobile number and Aadhaar, or by calling the PM-JAY helpline. Your district's Aarogyasri Resource Centre or the scheme desk at any empanelled government hospital can also verify your status. Many beneficiaries have a physical card, but the Aadhaar number alone is enough for verification at the hospital. If you are unsure whether your family is listed, ask the hospital's scheme desk to run a check before your treatment date is fixed.

The shortfall between the CGHS rate and the hospital's rate is the patient's responsibility unless the hospital is empanelled and has formally agreed to treat CGHS beneficiaries without balance billing. If an empanelled hospital is charging above the agreed rate, you can raise a complaint with the CGHS Additional Director for your city. If the hospital is not empanelled, you are only entitled to reimbursement at the CGHS-notified rate and the gap is yours to pay. Asking your oncologist to confirm the exact drug formulation and billing code can sometimes resolve a discrepancy, because CGHS rates apply to specific presentations of the drug.

Tell the insurer the name of the drug (cetuximab), that it will be given as a day care infusion, and the ICD-10 diagnosis code your oncologist has given you. Ask specifically whether day care monoclonal antibody infusions are covered, whether pre-authorisation is required and how to apply, and whether there is a sub-limit on oncology drugs. Have your policy number and the treating hospital's name ready. Ask for a reference number for the call — this matters if there is a dispute at the time of claim.

ESI covers comprehensive medical treatment for insured persons, and cancer care including expensive systemic therapy is included. The usual route to specialised treatment under ESI is a referral from your ESI dispensary or ESI hospital to a tie-up centre with oncology facilities. Prior approval is needed for high-cost biologics. If your ESI facility does not have an oncology department, ask for a formal referral letter — this is required for treatment at a tie-up hospital to be covered. Your employer's HR or payroll team can confirm your ESI registration status if you are unsure.

Tell your oncologist and the hospital's social work department directly that cost is a barrier — this is the most important step. The social worker can assess whether you qualify for any hospital hardship fund, connect you to cancer-specific charitable trusts, or find out whether a patient assistance programme is active for cetuximab. State cancer control programmes sometimes have drug support funds for patients at empanelled facilities. Your oncologist can also advise whether a clinical trial is open for your indication, since trial drugs are provided at no cost to participants. None of these routes open without the conversation happening first.

Government scheme authorisation is typically granted for an initial course of treatment. After that, the treating oncologist requests renewal or continuation authorisation based on your response. There is no fixed number of cycles that is universally covered — the scheme's medical committee reviews the continuing need at each renewal. Your hospital's scheme liaison will manage this process, but ask in advance how far ahead of the next renewal date they need to apply, so there is no gap in coverage between cycles.